Phosphorylation and Transport in the Na-K-2Cl Cotransporters, NKCC1 and NKCC2A, Compared in HEK-293 Cells by Hannemann, Anke & Flatman, Peter W.
Phosphorylation and Transport in the Na-K-2Cl
Cotransporters, NKCC1 and NKCC2A, Compared in HEK-
293 Cells
Anke Hannemann
¤, Peter W. Flatman*
Centre for Integrative Physiology, College of Medicine and Veterinary Medicine, The University of Edinburgh, Edinburgh, United Kingdom
Abstract
Na-K-2Cl cotransporters help determine cell composition and volume. NKCC1 is widely distributed whilst NKCC2 is only
found in the kidney where it plays a vital role reabsorbing 20% of filtered NaCl. NKCC2 regulation is poorly understood
because of its restricted distribution and difficulties with its expression in mammalian cell cultures. Here we compare
phosphorylation of the N-termini of the cotransporters, measured with phospho-specific antibodies, with bumetanide-
sensitive transport of K
+ (
86Rb
+) (activity) in HEK-293 cells stably expressing fNKCC1 or fNKCC2A which were cloned from
ferret kidney. Activities of transfected transporters were distinguished from those of endogenous ones by working at 37uC.
fNKCC1 and fNKCC2A activities were highest after pre-incubation of cells in hypotonic low-[Cl
2] media to reduce cell [Cl
2]
and volume during flux measurement. Phosphorylation of both transporters more than doubled. Pre-incubation with
ouabain also strongly stimulated fNKCC1 and fNKCC2A and substantially increased phosphorylation, whereas pre-
incubation in Na
+-free media maximally stimulated fNKCC1 and doubled its phosphorylation, but inhibited fNKCC2A, with a
small increase in its phosphorylation. Kinase inhibitors halved phosphorylation and activity of both transporters whereas
inhibition of phosphatases with calyculin A strongly increased phosphorylation of both transporters but only slightly
stimulated fNKCC1 and inhibited fNCCC2A. Thus kinase inhibition reduced phosphorylation and transport, and transport
stimulation was only seen when phosphorylation increased, but transport did not always increase with phosphorylation.
This suggests phosphorylation of the N-termini determines the transporters’ potential capacity to move ions, but final
activity also depends on other factors. Transport cannot be reliably inferred solely using phospho-specific antibodies on
whole-cell lysates.
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Introduction
Na
+-K
+-2Cl
2 cotransporters are major routes for transepithelial
movements of Na
+ and Cl
2 ions and consequently drive water
flow while K
+ is often recycled [1,2]. There are two major
isoforms, NKCC1 and NKCC2, which are products of different
genes (SLC12A2 and SLC12A1 respectively). Both are potently and
selectively inhibited by the loop-diuretic bumetanide which can be
used to identify and characterise transport. NKCC1 is found
mainly in the basolateral membranes of secretory epithelia where
it facilitates the entry of Na
+ and Cl
2 into cells from interstitial
fluid. NKCC1 is also widely expressed in non-epithelial cells where
it helps regulate cell composition and volume. NKCC2 is found
specifically in the apical membranes and subcellular vesicles of
cells in the thick ascending limb of Henle’s loop (TAL) in the
kidney. Here, as three splice variants (NKCC2A, -B and -F), it
reabsorbs about 20% of filtered NaCl from the urine, with
NKCC2A distributed throughout the whole TAL. The regulation
of NKCC1 has been extensively studied. Under conditions where
transport is stimulated (hypertonicity, low cell [Cl
2]) the
cotransporter becomes phosphorylated on three threonine residues
(equivalent to T204, T209, and T222 in ferret NKCC1
(fNKCC1)) in a key regulatory domain in the N-terminus of the
transporter [3,4]. Other studies show that phosphorylation of the
cotransporter by Ste20-related proline-alanine-rich kinase (SPAK)
and oxidative-stress response 1 (OSR1) kinase, is also critical in
transporter activation [5–7], and in this case, phosphorylation of
an over-lapping group of threonine residues (equivalent to T195,
T199 and T204 in fNKCC1) has been demonstrated [8,9]. Recent
studies show that phosphorylation of similar well conserved
residues in the N-terminus of NKCC2 (S91, T95, T100, T105
and T118 in both human and ferret NKCC2 (fNKCC2)) plays a
key role in regulating activity of this transporter too [10–12]. Once
again SPAK phosphorylates some of the residues [13]. These latter
findings are an important advance in understanding the regulation
of NKCC2, the study of which has been hampered by its highly
restricted natural expression, and by difficulties in stably
expressing the transporter in mammalian cell cultures [14–16].
In this paper we focus on the relationship between phosphor-
ylation and transport rate and the effects of ouabain on transport.
Given the problems of working with NKCC2, the ability to infer
its activity from measures of protein phosphorylation using suitable
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transport studies, would be of immense practical benefit in
studying kidney function, for instance its role in essential
hypertension. However, for NKCC1 there is evidence that some
factors, for instance those which alter its interactions with the
cytoskeleton, may influence transport rate independently of
cotransporter phosphorylation [17–19]. It is therefore necessary
to establish whether phosphorylation of NKCC2’s N-terminus is a
reliable index of transport rate. In addition we explore the effects
of ouabain, which is usually added during the measurement of
cotransporter fluxes to reduce background fluxes through the Na
+
pump.
Ferrets are used to model human cardiovascular physiology, for
instance study of NKCC1 in ferret erythrocytes has facilitated the
understanding of the transporter [18–20]. Previously we expressed
NKCC2 cloned from ferret kidney in HEK-293 cells [16]. All
three isoforms (A, B and F) were transiently expressed and carried
out significant bumetanide-sensitive transport. We now report the
functional expression of fNKCC1 and by comparing the
properties of fNKCC1 and fNKCC2A when stably expressed in
HEK-293 cells we show that, despite close similarities between
these transporters, especially within the regulatory domains in
their N-termini, and the common cellular environment in which
they are expressed, these transporters respond differently to several
stimuli. Importantly, phosphorylation does not always predict
cotransport activity and ouabain strongly activates both NKCC1
and NKCC2.
Materials and Methods
Chemicals were of analytical grade, and water was of Milli-Q
quality (Millipore). Drugs were prepared as 1006stock solutions.
4-amino-5-(4-methylphenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine
(PP1, Enzo Life Sciences, Farmingdale, NY), genistein (Sigma-
Aldrich), calyculin A (Enzo Life Sciences) were dissolved in
DMSO (Merck) whereas ouabain (Sigma-Aldrich) and bumeta-
nide (Leo Laboratories, Ballerup, Denmark) were dissolved in
water. Stock (200 mM) Na
+ orthovanadate (Sigma-Aldrich) was
prepared as described elsewhere [21].
86RbCl was from Perkin-
Elmer. Incubation media pH was adjusted to 7.4 with NaOH at
the appropriate temperature.
Compositions (in mM) of media were as follows. Basic (isotonic)
medium: 135 NaCl, 2.5 KCl, 1 CaCl2, 1 MgCl2, 5 glucose, 15
Hepes, pH 7.4. Hypotonic, low [Cl
2] medium: 67.5 Na
+
gluconate, 2.5 K
+ gluconate, 0.5 CaCl2, 0.5 MgCl2, 5 glucose,
15 Hepes, pH 7.4. Uptake medium: 135 NaCl, 1 RbCl, 1 CaCl2,
1 MgCl2, 5 glucose, 10 sorbitol, 0.1 ouabain, 15 Hepes, pH 7.4
and ,1 mCi/ml
86Rb
+. Lysis buffer: 50 NaF, 5 Na4P2O7,5
EDTA, 1 Na
+ orthovanadate, 1% Triton X-100, 1% protease
inhibitor cocktail (Merck), and 20 Hepes, pH 7.4. Na
+-free
medium was similar to basic medium but with all Na
+ replaced
by N-methyl-D-glucamine (NMDG), and Hepes neutralised with
Tris-base.
RNA isolation and Cloning of ferret NKCC1
Total RNA preparation from ferret kidneys and subsequent
cloning of the 59- and 39- regions of the fNKCC1 gene were
performed as described earlier [16] using fNKCC1 gene-specific
primers based on conserved regions of known vertebrate NKCC1
gene sequences. Using the sequence data obtained, the complete
open reading frame was amplified from random hexamer and
oligo-dT transcribed ferret kidney cDNA pools as two fragments
coding for either the N-terminus or C-terminus of fNKCC1, each
encompassing a unique BamHI restriction site in the second half of
the fNKCC1 gene (N-terminus: 59-CTG CCG GGG GTA CCG
CAG CGA TGG AAC C-39,5 9-ATC GAA TGT TGC AGT
GCA TTT AGG-39; C-terminus: 59-GGT AAT GAG CAT GGT
GTC AGG A-39,5 9-CAT GAG GGC TGT CCA GAA TTC
AGG GCC TTT AAG-39), and cloned into the pGEM-T-Easy
vector (Promega) to give pGEM-59-f1 and pGEM-39-f1, respec-
tively. The 59- and 39-NKCC1 fragments were subcloned into
pcDNA3.1 using a three way ligation to obtain the complete open
reading frame: pGEM-59-f1 was digested with KpnI/BamHI and
pGEM-39-f1 with BamHI/EcoRI and the resulting fragments were
ligated into the KpnI/EcoRI sites of pcDNA3.1. From that, the
complete fNKCC1 coding region was amplified using 59-GCT
GGC TAG CGT TTA GAA TTC AGC TTG GTA CCG CAG
CG-39 and 59-TAG AAG GCA CAG TCG AGG-39, inserted into
the EcoRI site of pCI-neo (Promega) and the obtained pCI-
fNKCC1 construct sequenced (CoGenics, Essex, UK).
Sequence data for fNKCC1 was deposited at GenBank under
accession number GQ338078.
Cell culture and stable cell lines
HEK-293 cells were maintained in Dulbecco’s Modified Eagle
Medium (DMEM) supplemented with 10% heat-inactivated fetal
bovine serum, 100 U/ml penicillin, 100 mg/ml streptomycin,
4 mM L-glutamine and, in case of stably transfected cells,
0.15 mg/ml Geneticin (Invitrogen). All cells were maintained at
37uC in a water-saturated atmosphere containing 95% air and 5%
CO2. To create a cell line stably expressing fNKCC1, HEK-293
cells were transfected with pCI-fNKCC1 using ExGen 500
(Fermentas, Ontario, Canada) according to the manufacturer’s
instructions and stable transfectants were selected by growth in the
presence of 0.3 mg/ml Geneticin. HEK-293 cells stably expressing
fNKCC2A have been described before [16]. Cells were plated
onto poly-d-lysine coated 96-well plates and grown to confluence
for 2–3 days before experimentation.
86Rb
+ uptake studies
NKCC activity was measured as bumetanide-sensitive
86Rb
+
influx in wild-type or stably transfected HEK-293 cells grown to
confluence in 96-well plates as described previously [16]. Fluxes
were measured at room temperature (RT; 20–25uC) or at 37uC.
Cells were washed and briefly incubated in basic medium,
followed by a three-step protocol. In step 1, the cells were
incubated for a total of 60 min in a pre-incubation medium. This
was either basic medium or a hypotonic, low [Cl
2] medium.
Drugs were added to basic medium during this period. Where
used, orthovanadate (1 mM) was present for the full 60 min
whereas DMSO (1%), calyculin A (0.25 mM), PP1 (50 mM), and
genistein (120 mM) were present for the final 30 min. In
experiments on the time-dependence of the effects of ouabain or
Na
+-removal, ouabain (0.1 mM) or the Na
+-free medium was
present for the last 5–30 min. In step 2 cells were incubated for
5 min in the final pre-incubation medium (containing any drugs)
or the Na
+-free medium with the addition of 0.1 mM ouabain. In
step 3
86Rb
+ uptake was measured in uptake medium containing
any drugs where indicated. Uptake was measured for 2–3 min at
RT, for 1 min at 37uC, and for 7 min when bumetanide was
present. In all cases the bumetanide-resistant uptake was measured
using an identical protocol but with 10 mM bumetanide present
during steps 2 and 3.
86Rb
+ uptake was terminated by removing
the uptake medium and washing cells three times in cold 110 mM
MgCl2 using an automatic plate-washer (Multiwash III; TriConti-
nent, Grass Valley, CA). Cell
86Rb
+ was determined with a
Typhoon phosphor imager (GE Healthcare). At least 3 wells were
used for each experimental point. Cell protein content for each
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86Rb
+. Cells were lysed in lysis buffer and protein concentration
was determined using a BCA protein assay (Pierce, Rockford, IL).
Phosphorylation of NKCC, SDS-PAGE and Antibodies
Wild-type and stably transfected HEK-293 cells were incubated
at 37uC as for Rb
+ uptake assays described above, but without
addition of
86Rb
+. After removal of uptake medium, the plates
were immediately placed on ice and cells were lysed in ice-cold
lysis buffer. Lysates from four wells were combined and their
protein content determined. SDS-PAGE and Western blotting
were performed as described previously [16]. Primary antibodies
were: N1 (0.5 mg/ml [16]), T4 (1:10000; Developmental Studies
Hybridoma Bank, Iowa City, IA), R5 (1:10,000; gift of B Forbush,
Yale), NKCC-P and anti-NKCC2 (1 mg/ml and 0.25 mg/ml; gifts
of DR Alessi, Dundee, UK); HRP-conjugated secondary antibod-
ies were: rabbit anti-sheep (1:60,000; Pierce) and goat anti-rabbit
or anti-mouse (1:20,000; Jackson ImmunoResearch). N1 is a
specific anti-NKCC1 rabbit polyclonal antibody raised to two
peptides in the N-terminus of human NKCC1 [16], T4 is a mouse
monoclonal antibody that binds to the C-terminus of both
NKCC1 and NKCC2 [22], and anti-NKCC2 is a sheep
polyclonal antibody raised to residues 1–174 in the N-terminus
of human NKCC2 [13]. R5 was raised to a di-phosphopeptide
(containing the equivalents of T204 and T209 in fNKCC1, or
T100 and T105 in fNKCC2A) and reacts with threonine residues
in NKCC1 and NKCC2 that are phosphorylated when the
transporter is activated by exposure to low cell [Cl
2] [11,23],
whereas NKCC-P reacts with the three threonine residues
phosphorylated by SPAK/OSR1 [8], which are equivalent to
T195, T199, T204 in fNKCC1 or S91, T95, T100 in fNKCC2A.
Equal loading of samples was confirmed by staining gels for
protein (GelCode Blue, Pierce) and comparing the optical densities
of bands using TotalLab (Non Linear Dynamics, Newcastle, UK).
A biotinylated protein ladder (Cell Signaling Technology,
Danvers, MA) was used for estimation of molecular mass.
Statistical analysis
Values are given as means 6 s.e.m. with n the number of
independent experiments. Occasionally, it was not possible to
repeat every component of an experiment because of cell
instability. Data analysis under these circumstances is described
in figure legends. Differences between normalised means were
assessed using two-tailed t-tests, with the level for significance set at
P,0.05. Non-linear regression analysis (one-phase association, no
weighting) was performed using Graph Pad Prism (version 5.0,
Graph Pad Software, San Diego, CA).
Results
Stable expression of fNKCC1
Ferret NKCC1 was cloned from adult kidney. The expressed
protein comprises 1204 amino acids with a calculated molecular
mass of 131 kDa (unglycosylated) and a pI of 6.03. The protein
has 95% and 94% similarity with human and mouse NKCC1
respectively. The threonine residues in the N-terminus regulatory
domain are conserved together with the surrounding sequence.
Also in the N-terminus are two consensus sites (
80RFQV and
130RFRV) for binding SPAK and OSR1 [5] and one site
(
132RVNF) for binding protein phosphatase 1 (PrP1) [24] which
partially overlaps with the second SPAK/OSR1 binding domain.
In SDS-PAGE, the full-length glycosylated protein migrates as
bands at approximately 155 kDa (Figure 2C) and also at 316 kDa.
When stably expressed in HEK-293 cells (fNKCC1 cells)
cotransport activity under isotonic conditions at RT was not
significantly different from that in untransfected cells (Figure 1A).
Incubation of fNKCC1 cells for 60 min in a hypotonic, low [Cl
2]
medium prior to flux measurement (in an isotonic medium) caused
a large activation of transport (Figure 1A), similar to that seen with
cells transfected with shark or human NKCC1 [25]. Activation
results from the large fall in cell [Cl
2] and the subsequent cell
shrinkage on return to an isotonic medium. This procedure is
frequently used to maximally activate NKCC1 [3,25] or NKCC2
[12]. It also increased phosphorylation of the N-terminus
regulatory domain of fNKCC1 as detected by two different
phospho-specific antibodies, R5 and NKCC-P (Table 1). Insertion
of fNKCC1 into the surface membrane was confirmed by its
detection amongst those proteins pulled down by streptavidin
beads following exposure of cells to a membrane-impermeant
biotinylation reagent (not shown; for methods see [16]).
Effect of temperature
Na
+-K
+-2Cl
2 cotransport is often measured in transfected cells
by growing them at 37uC in culture medium, then washing them
in a simplified buffer solution containing 0.1 mM ouabain, before
measuring K
+ (
86Rb
+) uptake in the presence of ouabain. The
latter steps are usually carried out at RT [16,25] which slows
uptake to allow more precise measurements. At RT (Figure 1A,
open bars), after isotonic pre-incubation bumetanide-sensitive
86Rb
+ uptake by fNKCC1 cells was indistinguishable from that by
control HEK-293 cells, whereas it was twice as high in HEK-293
cells expressing fNKCC2A (fNKCC2A cells). Exposure to a
hypotonic, low [Cl
2] medium was needed to distinguish fNKCC1
from HEK-293 NKCC (Figure 1A, filled bars). On raising the
temperature to 37uC cotransporter fluxes under isotonic condi-
tions were far larger in fNKCC1 and fNKCC2A cells than in
HEK-293 cells (Figure 1B, open bars). The rise in temperature
clearly reveals the presence of the transfected cotransporters,
particularly fNKCC1. Pre-incubation in a hypotonic, low-[Cl
2]
medium increased uptake in all three cell types at 37uC but the
effects were smaller than at RT (Figure 1B, filled bars). Although
we can calculate an approximate value for the temperature-
dependence from these data, more precise estimates require
correction for the effects of ouabain as described in the next
section.
Effect of ouabain
In the previous experiments cells were incubated with ouabain
for 5 min before flux measurement. The time was chosen to
facilitate addition of medium to the 96-well plates and to ensure
that all samples were treated similarly. However, we were
concerned that cell ion contents could change significantly when
cells were incubated with ouabain at 37uC and thereby influence
fluxes. Figure 2A shows the effects of changing the duration of
exposure to ouabain on the cotransport fluxes at 37uC.
Bumetanide-sensitive
86Rb
+ uptake increases substantially with
exposure time in fNKCC1 cells, but increases far less in HEK-293
cells and fNKCC2A cells. In order to assess whether Ca
2+ entry
via an active Na
+/Ca
2+ antiporter was responsible for the
stimulation of cotransport the experiments were repeated in the
absence of added external Ca
2+. Figure 2B shows that cotransport
stimulation was identical in the absence of external Ca
2+ ruling out
a role for Ca
2+ entry in this particular response.
Incubation of cells for 30 min with ouabain caused substantial
increases in the phosphorylation of fNKCC1 (4-fold) and
fNKCC2A (2–3 fold), and a smaller increase in that of endogenous
HEK-293 NKCC as detected by phospho-specific antibodies R5
and NKCC-P (Figure 2C, Table 1). These data suggest that at
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transporter phosphorylation, and not simply due to changes in
the concentrations of the cotransporter’s substrate ions.
Extrapolation of data in Figure 2A suggest that if the addition of
ouabain could have been made instantaneously the fNKCC1 and
fNKCC2A fluxes would have been 50 and 81% of the fluxes
measured at 5 min respectively. Correcting the data obtained at
37uC in Figure 1B for the effects of ouabain (it does not affect
cotransporter fluxes at RT, data not shown), the temperature
dependencies, expressed as Q10, of fNKCC1 and fNKCC2A
fluxes are 2.18 and 2.15 respectively. Data in Figure 2A also
indicate that the maximal rates seen after prolonged incubation in
ouabain are about 63% (HEK-293 and fNKCC1) or 90%
(fNKCC2A) of the values seen following pre-incubation in a
hypotonic, low [Cl
2] medium (Figure 1B, filled bars).
Incubation in a Na
+-free medium
Given that prolonged ouabain exposure, a manoeuvre that
raises cell [Na
+], activated both NKCC1 and NKCC2A we next
examined the consequences of pre-incubating cells in a nominally
Na
+-free (NMDG) medium (Figure 3). This caused a slight fall in
the activity of endogenous HEK-293 NKCC whereas the activity
of fNKCC1 more than doubled in 15 min, reaching values close to
those seen following incubation in a hypotonic, low [Cl
2]
medium. fNKCC2A activity on the other hand fell sharply by
34% within 5 min and then slowly increased over the following
30 min but did not fully return to its initial value. These changes in
transport were accompanied by changes in cotransporter phos-
phorylation measured 5 min after exposure to the Na
+-free
medium (Table 1). Phosphorylation of fNKCC1 approximately
doubled whereas that of the endogenous NKCC in HEK-293 and
fNKCC2A cells (155 kDa band), and of fNKCC2A increased by
30–60%.
Effects of kinase and phosphatase inhibitors on
86Rb
+
uptake
As regulation of NKCC activity is linked to phosphorylation of
key threonine residues in the N-terminus of the cotransporter we
tested the effect of different phosphatase and kinase inhibitors.
Concentrations and exposure times were chosen on the basis of
previous experience of these reagents on transport in other cells
[20,25], and to minimize deleterious effects on HEK-293 cell
viability. 0.25 mM Calyculin A (Figure 4A), a potent inhibitor of
protein phosphatases 1, 2A, 4, 5 and 6, which stimulates
86Rb
+
uptake in cells transfected with human NKCC1 [6], and in
erythrocytes [20,21] and shark rectal glands [3] had no effect on
bumetanide-sensitive
86Rb
+ uptake in untransfected HEK-293
cells (95.763.9% control, n=4), whereas it increased fluxes by
33.464.8% (n=6, P=0.001) in fNKCC1 cells, but slightly
reduced fluxes by 18.9610.3% (n=7, P=0.116) in fNKCC2A
cells. Although calyculin A increased fNKCC1 activity this
represents only about 15% of the stimulation seen when cells are
pre-incubated in hypotonic low [Cl
2], or low [Na
+] media.
Experiments on rat parotid acinar cells showed that Na
+
orthovanadate, an inhibitor of tyrosine phosphatases (as well as a
potent inhibitor of P-Class ATPases such as the Na
+ and Ca
2+
pumps), markedly inhibits the dephosphorylation of NKCC1 [26].
We therefore tested the effect of 1 mM orthovanadate on
bumetanide-sensitive
86Rb
+ uptake (Figure 4B). It had no effect
on uptake in HEK-293 (89.366.4% control, n=4) and fNKCC1
(100.263.6%, n=4) cells, but significantly inhibited
86Rb
+ uptake
in fNKCC2A cells by 20.662.1% (n=4; P=0.0023). In contrast
to these differential effects of phosphatase inhibitors, treatment of
cells with kinase inhibitors, 50 mM PP1 or 120 mM genistein,
reduced
86Rb
+ uptake in all three cell types by approximately 50%
(Figure 4C and D).
Effects of kinase and phosphatase inhibitors on NKCC
phosphorylation
Phosphorylation was assessed using R5 and NKCC-P after cells
had been treated with 0.25 mM calyculin A, 50 mM PP1 or
120 mM genistein at 37uC (Figure 5). In fNKCC2A cells, NKCC2-
specific bands were detected at ,134 kDa and at ,274 kDa
(possible dimer) in addition to endogenous NKCC at 155 kDa. In
HEK-293 and fNKCC1 cells there was one major band at
,155 kDa, comprising endogenous NKCC alone or with
fNKCC1. A minor band at ,316 kDa was occasionally observed
with T4 (NKCC1 dimer). As R5 and NKCC-P reported similar
Figure 1. Temperature-dependence of
86Rb
+ uptake.
86Rb
+ uptake in the absence or presence of 10 mM bumetanide was assessed following a
60 min pre-incubation in isotonic basic (open bars) or hypotonic, low [Cl
2]( filled bars) medium at either RT (A) or 37uC (B). Bumetanide-sensitive (B-S)
86Rb
+ uptakes are shown as mean 6 S.E.M. (n=9–14). In experiments designed specifically to assess the effects of increasing the temperature from RT
to 37uC,
86Rb
+ uptake increased by: fNKCC2A, 343613% (n=4); fNKCC1, 509622% (n=3); and HEK-293, 150649% (n=3) under basal conditions; and
by: 236636% (n=4), 106617% (n=5), and 145631% (n=3) following incubation in a hypotonic, low [Cl
2] medium. Bumetanide-resistant
86Rb
+
uptakes at 37uC in basic medium were (nmol mg protein
21 min
21): fNKCC2A, 1.8660.77 (n=10); fNKCC1, 1.9560.37 (n=10); and HEK-293, 1.0460.39
(n=8) and did not change substantially under any condition tested.
doi:10.1371/journal.pone.0017992.g001
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conditions, phosphorylation data have been pooled in Table 1.
Treatment with calyculin A led to a 3–5-fold increase in
phosphorylation of endogenous NKCC (in HEK-293 and
fNKCC2A cells) and a 5-fold increase in fNKCC1 phosphoryla-
tion observed at 155–175 kDa (Figure 5A, Table 1). In almost all
experiments, and with all three cell types, the majority of the R5
band at 155 kDa was replaced by a more slowly migrating band at
,175 kDa (Figure 5A and C, arrows). This ,20 kDa band-shift
was accompanied by a reduction in the intensity of the 155 kDa
band detected with NKCC1-specific antibody N1 (fell to
2865.9% control, n=5) and, to a smaller extent with T4 (fell to
6269.5% control, n=5). In the few cases where the band-shift was
not seen, there was no change in NKCC1-detection with N1 or
T4. fNKCC2 bands at both 274 and 134 kDa also showed
increased phosphorylation (4-fold and 60% respectively) after
calyculin A treatment (Figures 5A and B), but in this case there
were no band-shifts and nor were there changes in the intensities
of bands detected with anti-NKCC2 or T4 (Figure 5A and B).
Overall there was a poor correlation between changes in
phosphorylation and transport in the presence of calyculin A. In
HEK-293 cells increased phosphorylation of endogenous NKCC
was not accompanied by any significant change in cotransporter
fluxes, and in fNKCC1 cells, a five-fold increase in phosphory-
lation was accompanied by only a 30% increase in transport
(Figure 4A). For fNKCC2A a significant rise in phosphorylation
was accompanied by a small drop in transport (Figure 4A).
However, the kinase inhibitors PP1 (50 mM) and genistein
(120 mM) reduced phosphorylation of fNKCC1 and fNKCC2A
by about 50% (Figure 5D and E, Table 1) similar to the reduction
they caused in activity (Figures 4C and D). Total NKCC1 and
NKCC2 protein levels remained constant throughout these
experiments (Figure 5D and E).
Discussion
We describe the properties of fNKCC1 stably expressed in
HEK-293 cells and compare them with those of stably-expressed
fNKCC2A (62% sequence similarity), the NKCC2 isoform which
is present throughout the TAL and has similar ion affinities to
NKCC1 [27]. Fluxes through fNKCC1 and fNKCC2A could be
clearly distinguished from those through the endogenous HEK-
293 NKCC by making the measurements at 37uC. Similar high
rates of transport (100–130 nmol mg
21 min
21) were observed in
fNKCC1 cells following their pre-incubation in a hypotonic, low
[Cl
2] medium (Figure 1B), and surprisingly after preincubation in
Figure 2. Effect of ouabain on
86Rb
+ uptake and phosphorylation of fNKCC2A and fNKCC1. (A) time-dependent activation of
86Rb
+
uptake by ouabain. Bumetanide-sensitive (B-S)
86Rb
+ uptakes were measured at 37uC following pre-incubation of cells in an isotonic medium
containing 0.1 mM ouabain for the times indicated. Values are means 6 S.E.M. (n=4–7). Circles represent fNKCC1; squares, fNKCC2A; and triangles,
control HEK-293 cells. Lines, fitted to the data by non-linear regression analysis, are of the form: y=R+S(12exp(2kt)), where R is the initial, and R+S
the maximum uptake, k is the rate constant and t, the time in min. (B) Effect of omitting Ca
2+ from the medium during exposure to ouabain. Cells
were exposed to 0.1 mM ouabain and
86Rb
+ uptake was measured in the presence (open symbols) or absence (filled symbols) of 1 mM Ca
2+ in the
medium. Ca
2+-chelators were not used. (C) Lysates from cells exposed to ouabain (in the presence of Ca
2+) for 30 min were immunoblotted and
probed with antibodies against phospho-NKCC1 and 2 (NKCC-P, R5), NKCC2 (anti-NKCC2), NKCC1 and 2 (T4) and NKCC1 (N1). An indication of
molecular mass is shown to the right of each panel. Similar results were obtained when the experiment was repeated.
doi:10.1371/journal.pone.0017992.g002
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+-free medium (Figure 3), and may represent the maximum
achievable. fNKCC1 thus runs at about 20% maximum at 37uC,
similar to the level seen with the endogenous transporter in
erythrocytes [20]. The very low activity of fNKCC1 at RT
(Figure 1A) may result from the slight cell swelling and take up of
Cl
2 and Na
+ that occurs when cells are cooled. Even though the
largest fluxes through fNKCC2A were observed following pre-
treatment of cells in a hypotonic, low [Cl
2] medium, fNKCC2A
appears less sensitive to changes in cell [Cl
2] than fNKCC1
(Figure 1B). Indeed we generally observed that, with fixed external
substrate concentrations, many perturbations affected the activity
of fNKCC2A far less than that of fNKCC1. However, treatment
of cells with ouabain stimulated fNKCC2A (Figure 2) to about
90% of its highest level, whilst it stimulated fNKCC1 to about
63% of its maximal rate.
The links between phosphorylation of two neighbouring
domains in the N-termini of fNKCC1 and fNKCC2A and
transport rate (activity) were examined. Treatment of cells in a
variety of ways can produce similar patterns of phosphorylation,
but it is often difficult to assign these effects appropriately to those
kinases or phosphatases that phosphorylate or dephosphorylate the
cotransporter itself as kinase activation and phosphatase inhibition
have similar effects. What clearly emerges from our studies is that
inhibition of kinases reduces phosphorylation with proportional
changes in transport, and that transport stimulation is only seen
when phosphorylation increases from its basal level. However, it
does not always follow that an increase in phosphorylation results
in transport stimulation. Phosphorylation is necessary, but not
sufficient. Thus phospho-specific antibodies may provide impor-
tant information about cotransporter phosphorylation and the
integrity of cell signalling pathways but they may not be as reliable
for reporting cotransporter activity.
Both PP1, a kinase inhibitor selectively affecting Src, Lck, RIP2,
GAK, and CK1d [28], and genistein, a less selective inhibitor,
reduce the resting activities of fNKCC1, fNKCC2A and the
endogenous HEK-293 NKCC by about 50% (Figures 4C and D),
very similar to the effects seen in erythrocytes [19–21]. These
reductions in transport were accompanied by similar reductions in
cotransporter phosphorylation (Figures 5D and E, Table 1). Just as
with erythrocytes it was not possible to inhibit all
86Rb
+ uptake or
cotransporter phosphorylation using kinase inhibitors [18],
perhaps suggesting that persistent basal phosphorylation and
activity is a feature of these cotransporters. Although both
genistein and PP1 are often considered to be tyrosine kinase
inhibitors, changes in the tyrosine phosphorylation of NKCC1
which relate to changes in transport rate have not been observed
using either phospho-peptide mapping [3] or phospho-specific
antibodies [29]. Both inhibitors have broader specificity [28] so
whether genistein or PP1 inhibit the cotransporter kinases directly
or via up-stream kinases remains uncertain.
Incubation of cells in a hypotonic, low-[Cl
2] medium (Figure 1)
or with ouabain (Figure 2) activates both fNKCC1 and fNKCC2A
which is accompanied by 2–4 fold increases in their phosphory-
lation (Table 1). The effects of hypotonic, low-[Cl
2] pre-
incubation are caused, at least in part, by the activation of
SPAK/OSR1 [6,9,30], kinases that phosphorylate and activate
the transporters. However, the strong stimulation of fNKCC1,
fNKCC2A and endogenous NKCC by ouabain was not
anticipated, though it transpires that stimulation of loop-diuretic-
sensitive K
+ uptake (presumably via NKCC1) by ouabain had
been reported in cultured cells [31,32]. We ruled out that it was
secondary to a rise in cell [Ca
2+] as the same responses were seen
in cells incubated in Ca
2+-free media (Figure 2B), and nor did it
stem from the rise in cell [Na
+], or fall of cell [K
+], as vanadate,
another potent Na
+-pump inhibitor which should have similar
effects on cell ion contents, had no effect on fNKCC1 whilst it
slighted inhibited fNKCC2A (Figure 4B). An alternative possibility
is that ouabain itself, by binding to the pump, disturbs its
interaction with Src kinase, and thus activates signalling pathways
Table 1. Effects of inhibitors and changes to the ionic
environment on cotransporter phosphorylation.
Hypo/
low Ouabain
a
Na+-
freeb Calyculin PP1 Genistein
[Cl
2] 0.1 mM 0.25 mM5 0 mM 120 mM
fNKCC2A
cells
c
2134
kDa
2.360.3 1.960.3 1.360.1 1.660.1 0.460.1 0.560.1
2274
kDa
2.860.7 3.061.0 1.660.2 4.361.2 0.560.1 0.260.1
2155
kDa
2.460.5 2.260.4 1.360.1 5.362.0 0.360.1 0.560.1
fNKCC1
cells
2155
kDa
2.560.9 3.961.6 2.160.6 5.662.1 0.560.1 0.760.2
HEK-293
cells
2155
kDa
1.4 1.5 1.460.4 2.761.0 0.660.1 0.660.1
Phosphorylation levels detected by antibodies R5 and NKCC-P expressed as
factors of appropriate controls. Values are given as mean 6 S.E.M.( n $4) or as
averages if n=2.
aCells were exposed to ouabain for 35 min.
bCells were exposed to Na
+-free medium for 5 min.
c134 kDa and 274 kDa bands represent monomeric and dimeric fNKCC2A;
155 kDa bands, endogenous NKCC and fNKCC1. As antibodies R5 and NKCC-P
detect similar changes in cotransporter phosphorylation data have been
pooled.
doi:10.1371/journal.pone.0017992.t001
Figure 3.
86Rb
+ uptake after pre-incubation in Na
+-free
medium. Bumetanide-sensitive (B-S)
86Rb
+ uptake was measured at
37uC in confluent HEK-293 cells (triangles), fNKCC2A cells (squares)o r
fNKCC1 cells (circles). Cells were pre-incubated in a Na
+-free (NMDG)
medium for the times indicated with 0.1 mM ouabain present for the
last 5 min.
86Rb
+ uptake was then measured in the presence of Na
+.
Points represent means 6 S.E.M. (n=5–11).
doi:10.1371/journal.pone.0017992.g003
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activity [18,20]. These findings may be physiologically significant
as the levels of endogenous ouabain-like compounds fluctuate in
the circulation [34] and could thus affect Na
+ reabsorption in the
TAL. Our findings also suggest that care must be taken when
using ouabain during measurement of cotransporter fluxes.
Several treatments had opposite effects on transport mediated
by either fNKCC1 or fNKCC2A. Initially we hypothesised that
these differences might result from the ability of NKCC1, but not
NKCC2, to bind the catalytic subunit of PrP1 [11,24]. This bound
PrP1 could then dephosphorylate both NKCC1 itself, and SPAK/
OSR1 bound to NKCC1 at an adjacent site [35]. Thus
manoeuvres that affect PrP1 might change the phosphorylation
and activity of fNKCC1 directly as well as indirectly by affecting
the activity of SPAK/OSR1, whilst they would not be expected to
affect fNKCC2A. However, measurements of phosphorylation did
not support this hypothesis.
Calyculin A activated fNKCC1 and caused a slight inhibition of
fNKCC2A (Figure 4A). This is consistent with the model above
and with the previous observations that calyculin does not activate
transport by NKCC2 expressed in Xenopus oocytes [12], and that it
only stimulates transport in cultured TAL cells by 20% [36]. In
contrast, phosphorylation of both fNKCC1 and fNKCC2A
increased substantially (Figure 5, Table 1). For fNKCC2A this
increase was especially unexpected given the effect on transport,
but supports the idea that PrP1 bound to other chaperones, for
instance apoptosis-associated tyrosine kinase, might also reduce
cotransporter phosphorylation [37]. However, even for fNKCC1 a
5-fold increase in phosphorylation was associated with only a 30%
increase in transport, far below the transporter’s capacity to
respond under other conditions (Figures 1B, 2A, 3 and Table 1).
This suggests that while phosphorylation of the regulatory
domains in the N-terminus determines the transporter’s potential
capacity to move ions, the actual activity also depends on a variety
of other factors. For calyculin, which inhibits many phosphatases
in addition to PrP1 (with consequent activation of kinases), we
hypothesise that cotransporter hyperphosphorylation may inhibit
transport. One possibility is that cotransporters have sites whose
phosphorylation inhibits transport. Alternatively the effect may be
indirect, for example phosphorylation of a particular site may
reduce the transporters’ cell surface expression, either by reducing
trafficking to the plasma membrane, or by stimulating removal
from the surface and possibly destruction in the proteasome.
Calyculin causes large proportionate increases in phosphorylation
and transport (NKCC1) in erythrocytes [21]. In these cells
trafficking does not affect surface expression of transporters
favouring the view that calyculin’s inhibitory effects stem from it
interfering with trafficking.
fNKCC1 and fNKCC2A also responded differently when cells
had been pre-incubated in a [Na
+]-free medium (Figure 3 and
Figure 4. Effects of phosphatase and kinase inhibitors on
86Rb
+ uptake. Cells were pre-incubated at 37uC in basic medium for 30 min
followed by 30 min in basic medium in the absence (control) or presence of: 1% DMSO (vehicle), 0.25 mM calyculin (A), 1 mM orthovanadate for the
entire 60 min (B), 50 mM PP1 (C) or 120 mM genistein (D) before measuring
86Rb
+ uptake in the presence of the drugs. Bumetanide-sensitive (B-S)
86Rb
+ uptakes are shown as mean 6 S.E.M. (n=3–7, values for HEK-293 cells in B and C are means of triplicates in a single experiment). Using paired,
normalised comparisons * signifies P,0.05.
86Rb
+ uptakes in the presence of DMSO were (% control): fNKCC2A, 91.762.4 (n=6); fNKCC1, 93.065.2
(n=6); and HEK-293, 10165.7 (n=3), none significantly different from controls.
doi:10.1371/journal.pone.0017992.g004
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phosphorylation doubled, whereas fNKCC2A was inhibited, with
perhaps a small rise in its phosphorylation. Incubation of cells in a
Na
+-free medium would be expected to deplete their intracellular
[Na
+] at a rate that depends on the Na
+ pump and the availability
of additional Na
+ efflux routes. As transfected fNKCC1 and
fNKCC2A provide such routes, intracellular [Na
+] could fall to a
low level at different rates. However, this is unlikely to cause
substantial differences in cell [Na
+] over the time course of our
experiments given the contribution of the Na
+ pump, and the
similar maximal transport rates and ion affinities of the isoforms
involved. Changes in cell [Na
+] could then cause secondary
changes in cell [Ca
2+] and pH. The effects external Na
+-removal
on these variables have been documented for a few cell types, for
instance cardiac myocytes [38], but is beyond the scope of the
current study. Thus it is not possible to identify the precise change
that causes the different responses of fNKCC1 and fNKCC2A, but
it is clear that striking differences are apparent after 5 min
exposure to a Na
+-free medium and are maintained for at least the
next 30 min. The simplest explanation is that reductions in cell
[Na
+] affect phosphorylation and/or trafficking of fNKCC1 and
fNKCC2A differently and suggest that cell [Na
+], in addition to
being a substrate, may regulate cotransport.
Recently, NKCC1 and NKCC2F, expressed in Xenopus oocytes,
were shown to behave differently when the medium was made
hypertonic by addition of sucrose [39]. Whereas
86Rb
+ uptake by
NKCC1 was strongly stimulated, uptake by NKCC2F only rose
slightly. In addition, the stimulated uptake through NKCC1
represented K
+-K
+ exchange [39,40], perhaps facilitated by the
rise in intracellular ion concentrations (particularly Cl
2) under
these conditions, and perhaps suggesting that NKCC1 is more
prone to this mode of transport than NKCC2F. It is likely that
some K
+-K
+ exchange contributes to
86Rb
+ uptake measured
here. However, the ion gradients favoured net influx (rather than
K
+-K
+ exchange) under most conditions (and cell [Cl
2] was often
reduced), except perhaps after long exposure to ouabain, where a
rise in intracellular [Na
+] might favour self-exchange. Conversely,
a fall in K
+-K
+ exchange might explain the slight drop in
86Rb
+
uptake seen in HEK-293 cells incubated in a Na
+-free medium.
The differences between fNKCC2A and fNKCC1 shown in this
study - ranging from fNKCC2A’s higher resting activity to its
reduced responsiveness to a variety of stimuli - are in line with the
different locations and physiological roles of the transporters.
Changes in urine ion concentrations may be the major determinant
of NKCC2A activity (load-dependent) whereas there is limited
scope for variation in extracellular ion concentrations for NKCC1,
and the actions of hormones and cytokines may be much more
important. NKCC2A has a steadier work-load (in man 1 mole of
Na
+ is filtered each hour, day or night, and must be reabsorbed,
dietary fluctuations represent a tiny fraction of this), whereas for
NKCC1 activity may have to be low at rest but be capable of rising
rapidly to deal with high peak demands. Strong activation by a fall,
and inhibition by a rise in cell [Cl
2] or [Na
+] makes physiological
sense for NKCC1, but not for NKCC2 where such effects would
Figure 5. Effects of phosphatase and kinase inhibitors on phosphorylation of fNKCC2A and fNKCC1. Experiments were carried out as
described in Figure 4, but without the addition of
86Rb
+. Cell lysates were subjected to SDS-PAGE, immunoblotted, and probed with antibodies
against phospho-NKCC1 and 2 (NKCC-P, R5), NKCC2 (anti-NKCC2), NKCC1 and 2 (T4) and NKCC1 (N1). Representative blots are shown with control
and drug-treated samples from the same blot. Estimated molecular mass is indicated to the right of each panel. (A) Effect of 0.25 mM calyculin A on
monomeric NKCC. An approximate 20 kDa band-shift in calyculin-treated cells is only observed with the phospho-specific antibody R5 (arrow) but
not with NKCC-P. (B) High molecular mass bands in calyculin A treated fNKCC2A cells. (C) Example of 20 kDa band-shift (arrow) in HEK-293 cells. Cells
had been pre-incubated in basic medium, a Na
+-free medium or with calyculin. (D) Effect of 50 mM PP1 and 120 mM genistein on monomeric NKCC.
(E) High molecular mass bands in PP1 or genistein treated fNKCC2A cells.
doi:10.1371/journal.pone.0017992.g005
Regulation of NKCC1 and NKCC2
PLoS ONE | www.plosone.org 8 March 2011 | Volume 6 | Issue 3 | e17992limit the ability of the transporter to respond to changes in urine ion
concentration. Here, it is important that both Cl
2 and Na
+ are
allowed to pass through the epithelium without raised cell levels
unduly inhibiting further entry on the cotransporter.
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